Work

Pharmacokinetics (PK), pharmacodynamics (PD) and immunogenicity of moxetumomab pasudotox (Moxe), an immunotoxin targeting CD22, in adult patients (Pts) with relapsed or refractory hairy cell leukemia (HCL).

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.7061

Authors: Kemal Balic, Nathan Standifer, Linda Santiago, Denison Kuruvilla, Nai-Shun Yao, Robert J. Kreitman, Ira Pastan, Xia Li, Meina Liang, Inna Vainshtein, Chih-Ming Tseng, Raffaella Faggioni, Lorin Roskos

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891889126

Cites:

Cited by: 2

Related to: 10